Delivery Order SPE2DB24D2205-SPE2DB25FEJAM
Award Date 9/25/25
Potential Completion Date 9/26/25
Potential Value $8.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $8,866.94 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 ml syringes on August 25, 2025, with a completion date of August 26, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, executed through competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Monovisc is...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $14,155.08 on July 18, 2025, for the supply of Monovisc 88 mg/4 mL syringes through the Defense Logistics Agency Medical Supply Chain. The contract represents a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and involves no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Monovisc is a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,551.43 on August 13, 2025, for the supply of Monovisc 88 mg/4 mL syringes. This firm fixed-price delivery order, which carries an ultimate completion date of August 14, 2025, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Monovisc is a viscosupplement injection used primarily for osteoarthritis joint pain...
- The Defense Logistics Agency awarded a delivery order valued at $1,221.75 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 ml syringes (4 ml quantity) on June 18, 2025, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Monovisc is a viscosupplement injection used to treat osteoarthritis pain,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,266.96 on July 18, 2025, for the supply of MONOVISC 88 mg/4 mL syringes (4 mL quantity) under a firm fixed-price contract. The award, which carries an ultimate completion date of July 21, 2025, was funded by the Defense Logistics Agency's Medical Supply Chain division and performed at the company's corporate office location in Conshohocken, Pennsylvania. This non-competitive delivery order represents a continuation of...
- The Defense Logistics Agency awarded a delivery order valued at $2,962.22 to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 mL syringes on September 5, 2025, with completion targeted for September 8, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Monovisc is a viscosupplement injection used to treat osteoarthritis pain, representing one of the specialized...
- The Defense Logistics Agency awarded a delivery order valued at $9,013.11 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Monovisc 88 mg/4 ml syringes. The contract is a firm fixed-price delivery order with a completion date of August 6, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $4,819.92 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 ml syringes on August 27, 2025, with completion scheduled for August 28, 2025. This non-competitive, firm fixed-price delivery order represents a single procurement under AmerisourceBergen's larger contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency awarded a $8,222.46 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Monovisc 88 mg/4 mL syringes (4 mL quantity). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 15, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Monovisc 88 mg/4 ml syringes. This firm fixed price delivery order, valued at $7,229.88, represents a non-set-aside award and is due for completion by August 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Monovisc is a viscosupplement injection used in orthopedic and...